Scholars@Duke
Nosayaba Osazuwa-Peters

Nosayaba Osazuwa-Peters

Associate Professor in Head and Neck Surgery & Communication Sciences
Head & Neck Surgical Oncology
4212 Orange Zone, Box 3805, Durham, NC 27710
DUMC 3805, Durham, NC 27710

Scholarly Works - Conferences

2085P Buprenorphine use and cancer outcomes

Conference Annals of Oncology · October 2023 Full text Cite

Abstract 4360: Opioid, non-opioid, and non-pharmacological pain management in patients with a history of cancer

Conference Cancer Research · April 4, 2023 AbstractBackground Pain is highly prevalent among individuals with cancer. Consequently, adequate and equitable pain management are hallmarks of quality cancer care. Unfortunately, up to one-third of patient ... Full text Cite

Abstract A130: Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public and alternative settings

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractIntroduction: Hospitals and private healthcare facilities are the primary setting for administering the human papillomavirus (HPV) vaccine. A goal of the President's Cancer Panel on HPV vaccination i ... Full text Cite

Abstract A124: Disparities in HPV vaccine uptake and provider recommendation by provider facility type

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractBackground: Approximately 46,000 cases of human papillomavirus (HPV) attributable cancers are diagnosed annually in the United States. The HPV vaccine can prevent over 90% of HPV-attributable cancers ... Full text Cite

Abstract C072: Statewide variability in predictors of survival among geographically and racially diverse breast cancer cohorts

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractIntroduction The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides free breast cancer screening, case management, patient navigation, and connection to treatment for medi ... Full text Cite

Abstract P018: Differences in guideline-recommended age of human papillomavirus (HPV) vaccine initiation and completion in the United States

Conference Cancer Prevention Research · January 1, 2023 AbstractBackground: While there has been increase in the uptake of the human papillomavirus (HPV) vaccine, current vaccine rate fell short of the Healthy People 2020 target. The Centers for Disease Control a ... Full text Cite

Abstract P023: The impact of limited English proficiency and healthcare access on HPV vaccine uptake in the United States

Conference Cancer Prevention Research · January 1, 2023 AbstractBackground: Limited English proficiency (LEP) impacts patient-provider communication and access to healthcare, both of which are also associated with human papillomavirus (HPV) vaccine uptake. We exa ... Full text Cite

Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.

Conference Oral Oncol · November 2022 OBJECTIVE: This study assesses longitudinal epidemiologic trends in the oldest head and neck cancer (HNC) patients, comparing the oropharynx to other mucosal HNC sites. MATERIALS AND METHODS: Using data from the Surveillance, Epidemiology, and End Results ... Full text Link to item Cite

Cancer Mortality and the 2014 Medicaid Expansions under the Affordable Care Act

Conference INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS · November 1, 2022 Link to item Cite

Abstract PO-271: Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among adults aged 27-45 years in the United States

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2022 AbstractBackground: More than 36,000 new cases of human papillomavirus (HPV)-associated cancers are diagnosed annually in the United States, with racial/ethnic differences observed in incidence and mortality ... Full text Cite

Sociodemographic differences in patient-reported pain and pain management of head and neck cancer patients in a community oncology setting.

Conference Journal of Clinical Oncology · October 1, 2021 150 Background: There are currently 500,000 head and neck cancer (HNC) survivors in the United States. Pain is common among survivors and associated with adverse quality of life and outcomes. There is however a lack of data on pa ... Full text Cite

Depression, chronic pain, and high-impact chronic pain among cancer survivors.

Conference Journal of Clinical Oncology · May 20, 2021 12085 Background: The majority of the 17 million individuals living with a cancer diagnosis in the United States have experienced pain, either from the disease itself or from its treatment. Pain negatively impacts psychosocial qu ... Full text Cite

Abstract A05: Incidence and trends in head and neck cancer among United States’ pediatric, adolescent, and young adult population

Conference Cancer Research · July 15, 2020 AbstractObjectives: In 2009, there were 48,010 new cases of head and neck cancer in the United States. A decade later, it is projected that there will be 65,410 new cases in 2019, a 36% increase in new cases ... Full text Cite

Abstract B088: Health insurance status, stage at presentation and survival among female patients with head and neck cancer

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2020 AbstractIntroduction: Head and neck cancer epidemiology has historically focused on the burden of disease among males. Despite a concerning increase in the incidence of certain types of head and neck cancer ... Full text Cite

Impact of the Affordable Care Act (ACA) on the Rate of Untreated Head and Neck Cancer

Conference International Journal of Radiation Oncology*Biology*Physics · September 2019 Full text Cite

Abstract 4221: Factors associated with HPV vaccination initiation and completion among 18-26 year olds in the United States

Conference Cancer Research · July 1, 2017 AbstractBackground The HPV vaccine prevents HPV-associated cancers and genital warts, which cause significant morbidity and mortality in the US. While the vaccine is targeted toward 11-12-year-old boys and g ... Full text Cite

Abstract 268: Tracking HPV vaccination of young boys: is parental recall as dependable as physician records

Conference Cancer Research · July 1, 2017 AbstractIntroduction: HPV vaccine is administered to young boys and girls aged 11-12 years in multiple doses rather than single dose. The interval between doses is critical as well as completion of the dose ... Full text Cite

Abstract B79: Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States

Conference Cancer Epidemiology, Biomarkers & Prevention · February 1, 2017 AbstractBackground:Human Papillomavirus (HPV) is associated with multiple cancers and remains the most common sexually transmitted infection in the United States. Each year, ... Full text Cite

Abstract B78: The interplay between smoking at diagnosis, marital status, and head and neck cancer survivorship

Conference Cancer Epidemiology, Biomarkers & Prevention · February 1, 2017 AbstractBACKGROUNDThere are currently almost 300,000 head and neck cancer survivors in the United States, and that number is increasing due to a nationwide decrease in smokin ... Full text Cite

Abstract 1785: Sociodemographic correlates of knowledge and risk perception of HPV and HPV-associated oropharyngeal cancer

Conference Cancer Research · July 15, 2016 AbstractPurposeTo analyze how key sociodemographic variables correlate with risk perception and knowledge of HPV-associated oropharyngeal cancer in the community. ... Full text Cite

Abstract 1430: Do race and gender independently predict risk factors associated with the Human papillomavirus

Conference Cancer Research · July 15, 2016 AbstractPurposeTo assess racial and gender differences, among a drag racing population, as predictors of sexual risk factors associated with HPV infection, including number o ... Full text Cite

Abstract 1787: Adolescent boys and the human papillomavirus (HPV) - Geographical patterns of vaccination uptake

Conference Cancer Research · July 15, 2016 AbstractINTRODUCTIONHuman Papillomavirus (HPV) remains the most common sexually transmitted infection (STI) and is associated with multiple cancers. Previous research has exa ... Full text Cite

Abstract 3472: Does being married independently predict survival in patients with head and neck cancer? Results from a single institution

Conference Cancer Research · July 15, 2016 AbstractPurpose/ObjectivesAn important factor in cancer survivorship is social support, often coming from a spouse. There is an emerging literature on the role of spousal sup ... Full text Cite

Abstract 2577: A comparison of parent and provider verified HPV vaccination initiation and completion in US adolescents: findings from the National Immunization Survey - Teen, 2014

Conference Cancer Research · July 15, 2016 AbstractIntroduction:Several studies have examined predictors of HPV vaccine initiation and completion. Two common methods to measure HPV vaccine initiation and completion ar ... Full text Cite

Abstract A52: Sociodemographic predictors of HPV and HPV vaccine knowledge and awareness among Americans who use the Internet as their primary source of health information

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractBackground: There is a growing need to provide digital access to accurate and up-to-date health information as millions of Americans now consider the internet their primary source of health informati ... Full text Cite

Abstract A51: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine in a national sample of U.S. adults

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractBackground: Nearly 80 million people in the U.S. are currently infected with at least one of two strains of human papillomavirus (HPV), which is associated with 70% of cervical, and more than 90% of ... Full text Cite

Abstract A60: A paradox: Engaging in at-risk behavior may not correlate with perceived susceptibility to cancer or heart disease

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractBackground: The Health Belief Model states that behavioral change is highly influenced by perceived susceptibility to disease. The literature shows that physical activity, nutrition, and smoking are ... Full text Cite

Abstract B58: Assessing university students' sexual risk behavior, knowledge of the human papillomavirus, (HPV), HPV vaccine, and association between HPV and head and neck cancer

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractBackground/Objectives: There has been a 225% increase in the incidence of oropharyngeal cancer, a sub-site of head and neck cancer, in the United States in the last three decades. This massive increa ... Full text Cite

Abstract B70: Characteristics, risk perception, and predictors of oral cancer knowledge among drag racers and their fans

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractObjective: Interventions for oral head and neck cancer prevention and early detection can be more effective if the higher risk individuals are targeted. The aim of this study was to characterize smok ... Full text Cite

Abstract B89: HPV is not just a woman's business! Understanding the gaps in men's knowledge of HPV and HPV vaccine

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractBackground: The human papillomavirus (HPV) vaccine was first approved for use in females in 2006, and then in 2009, for both males and females. However, the knowledge of HPV and HPV vaccine, and upta ... Full text Cite

Abstract C47: Gender and racial disparities in long-term survival of oral and oropharyngeal cancer in the United States

Conference Cancer Epidemiology, Biomarkers & Prevention · March 1, 2016 AbstractPurpose: Increased survivorship of head and neck cancer necessitates longer-term care for patients. However, no previous study from the United States has described head and neck survivorship beyond 1 ... Full text Cite